These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 367896)

  • 21. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
    Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
    Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoimmunotherapy for disseminated malignant melanoma with DTIC, ACNU, VCR and OK432. Case presentation of two complete and one partial reponse out of fifteen attempts.
    Chiba M; Jimbow K; Kizukuri K; Homma K
    J Dermatol; 1982 Feb; 9(1):23-30. PubMed ID: 7047605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
    Zaumseil RP; Wohlrab W; Fiedler H; Wozniak KD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):721-4. PubMed ID: 6172340
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 25. New treatments for malignant melanoma.
    Luce JK
    Cancer Treat Rep; 1978 Dec; 62(12):2009. PubMed ID: 751710
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update.
    Block JB; Tabbarah H; Isacoff W; Drakes TP
    J Dermatol Surg Oncol; 1979 Feb; 5(2):118-23. PubMed ID: 762295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of a new nitrosourea compound: fotemustine].
    Boaziz C
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):964-8. PubMed ID: 1338920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
    Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
    Satoh S; Suzuki A; Okamura H; Nishimura T
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):140-5. PubMed ID: 6820877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
    Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
    J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P; Dreno B; Bureau B; Litoux P
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DTIC in malignant melanoma: a perspective (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr; 1978 Dec; 90(24):870-4. PubMed ID: 369152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoimmunotherapy for melanoma with DTIC, ACNU, VCR and OK432: evaluation of new combinations for survival rates, side effects and cellular immunity.
    Jimbow K; Yanbe H; Nishio C
    J Dermatol; 1981 Aug; 8(4):259-66. PubMed ID: 7028826
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
    Wood WC; Cosimi AB; Carey RW; Kaufman SD
    Surgery; 1978 Jun; 83(6):677-81. PubMed ID: 644461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Povlsen CO; Jacobsen GK
    Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.
    Beretta G; Bonadonna G; Cascinelli N; Morabito A; Veronesi U
    Cancer Treat Rep; 1976 Jan; 60(1):33-40. PubMed ID: 1000518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of disseminated malignant melanoma. Results are promising, but toxicity is high].
    Brunet A
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):960-3. PubMed ID: 1303493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of melanoma.
    Luce JK
    Semin Oncol; 1975 Jun; 2(2):179-85. PubMed ID: 1234375
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapy of malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent developments in chemotherapy of malignant diseases].
    Moser K; Pohl A
    Wien Klin Wochenschr; 1982 Dec; 94(23):640-8. PubMed ID: 6188282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.